Narrativa and Insud Pharma simplify clinical trials with generative AI
Narrativa and Insud Pharma simplify clinical trials with generative AI
New Partner
New Partner
New Partner
Insud Pharma, a top pharmaceutical company, is teaming up with Narrativa, a global generative AI software company for life sciences, to fast-track its clinical trials by automatically generating large portions of the clinical trial regulatory documentation. This collaboration will help to improve the overall timeline and accuracy of the drug discovery process and mitigate risks in the regulatory approval process.
Accelerating clinical trial approvals with AI-powered medical writing
Insud Pharma and Narrativa will simplify clinical trials with artificial intelligence by transforming data from clinical trials into regulatory documentation. This will be possible thanks to the Narrativa proprietary platform, Narrativa Navigator, powered by a powerful combination of generative AI models and a proprietary knowledge graph. Narrativa Navigator helps to assist medical writers by automating patient narratives, CSRs (clinical study reports), TLFs (tables, listings and figures), and other portions of the regulatory reporting process. The technology will allow medical writers the opportunity to:
- Reduce time to market by accelerating the approval process, providing the first initial drafts of each document so writing teams can allocate more time to quality control activities
- Reduce risks by having the data analysis and reporting done by machines
- Reduce costs by requiring fewer medical writers
- Reduce complexity by involving fewer stakeholders in the process
“We’re aiming to make a positive impact in the clinical trial industry,” says Jennifer Bittinger, Narrativa’s President. “By using AI to handle large portions of clinical trial documentation, we can help to accelerate the approval of new treatments to patients faster and save more lives.”
About Insud Pharma
Insud Pharma is a pharmaceutical group with a track record spanning over 45 years and a footprint in more than 50 countries, led by Leandro and Lucas Sigman. Their overarching goal is to improve people’s health all over the world, providing accessible, effective, safe, quality medicines through their various business units, underpinned by continuous investment in R&D and cutting-edge technology at all their centers.
For more info, visit www.insudpharma.com.
About Narrativa
Narrativa® is the global leader in generative AI content automation. Through the no-code Narrativa® Navigator platform and the collaborative writing assistant, Narrativa® Sidekick, organizations large and small are empowered to accelerate content creation at scale with greater speed, accuracy, and efficiency.
For companies in the life sciences industry, Narrativa® Navigator provides secure and specialized AI-powered automation features. It includes complementary user-friendly tools such as CSR Atlas, Narrative Pathway, TLF Voyager, and Redaction Scout, which operate cohesively to transform clinical data into submission-ready regulatory documents. From database to delivery, pharmaceutical sponsors, biotech firms, and contract research organizations (CROs) rely on Narrativa® to streamline workflows, decrease costs, and reduce time-to-market across the clinical lifecycle and, more broadly, throughout their entire businesses.
The dynamic Narrativa® Navigator platform also supports non-clinical industries such as finance, marketing, and media. It helps teams drive measurable impact by creating high-quality, scalable content on any topic. Available as a self-serve SaaS solution or a fully managed service, built-in AI agents enable the production, refinement, and iteration of large volumes of SEO-optimized news articles, engaging blog posts, insightful thought leadership pieces, in-depth financial reports, dynamic social media posts, compelling white papers, and much more.
Explore www.narrativa.com and follow on LinkedIn, Facebook, Instagram, and X. Accelerate the potential with Narrativa®.
